Plain-English translation of NCT07143110 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Neoplasms research guide →LUNG-ROLL is a study that examines the medical records of about 60,000 people diagnosed with lung cancer in Alberta and Ontario since 2018. Researchers will look at what treatments patients received, how well those treatments worked, and what the overall cost of care was. This information will help doctors and healthcare planners better understand how lung cancer is currently being treated in Canada.
Doctors and healthcare leaders need clear information about how lung cancer patients are being treated in Canada and what the real costs of that care are. This study will provide that information so that healthcare systems can make better decisions about treatment options and resource planning.
You likely qualify if…
You likely don't qualify if…
This study does not involve any visits, appointments, or active participation on your part. Instead, researchers will review your existing medical records that are already held by Alberta and Ontario's healthcare systems to gather information about your diagnosis, treatments, and outcomes. You would simply be allowing your anonymized health information to be used for this research.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
Canada
Sponsor
AstraZeneca
Enrollment target
~60,000 participants
Started
August 2025
Primary completion
September 2027
Age range
18 Years – 130 Years
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
AstraZeneca Clinical Study Information Center
AstraZeneca
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.